Calmmm down, realist. The science behind bavi has proved in PhI and PhII clinical trials, and Dr. Garnick (among others) has seen more than either of us. Now he's joined Peregrine, "advancing its novel monoclonal antibody-based treatments for cancer and infectious diseases." We'll see where it goes, but my money's on Garnick, not you.
Market Data 
Markets 
AI
